Photographer: Felipe Caparrós Cruz/Getty Images
Health Care

These Drugs Could Save the U.S. Billions of Dollars. Would You Take Them?

One class of generic biologics is similar in safety and effectiveness to its brand-name counterparts, a study finds.

They used to be considered unlikely challengers to brand-name biologic drugs. Now some estimate (PDF) that they could save the U.S. health-care system tens of billions of dollars by 2024—once they win regulators' approval.  

To continue reading this article you must be a Bloomberg Professional Service Subscriber.